about
Options for Controlling Type 2 Diabetes during RamadanPersonalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfallsDiabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future researchPeripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomesInterplay between ultrastructural findings and atherothrombotic complications in type 2 diabetes mellitusCoronary artery revascularization in patients with diabetes mellitusPathogenesis of diabetic cerebral vascular disease complicationAspirin dose for prevention of cardiovascular disease in diabeticsObesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjectsAspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus trePotential Role of Protein Disulfide Isomerase in Metabolic Syndrome-Derived Platelet HyperactivityStatins but not aspirin reduce thrombotic risk assessed by thrombin generation in diabetic patients without cardiovascular events: the RATIONAL trialThe current role of thiazolidinediones in diabetes management.Mean platelet volume in Type 2 diabetes mellitus.Diabetes and vascular disease in different arterial territories.Evaluation of mean platelet volume in patients with type 2 diabetes mellitus and blood glucose regulation: a marker for atherosclerosis?Topiramate improves neurovascular function, epidermal nerve fiber morphology, and metabolism in patients with type 2 diabetes mellitus.Activated platelets from diabetic rats cause endothelial dysfunction by decreasing Akt/endothelial NO synthase signaling pathwayAdipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.A pharmacogenetics-based warfarin maintenance dosing algorithm from Northern Chinese patients.Impact of age, CYP2C9 genotype and concomitant medication on the rate of rise for prothrombin time during the first 30 days of warfarin therapy.Investigation of mean platelet volume in patients with type 2 diabetes mellitus and in subjects with impaired fasting glucose: a cost-effective tool in primary health care?Mean platelet volume and platelet counts in type 2 diabetes: mellitus on treatment and non-diabetic mellitus controls in Lagos, Nigeria.Targets and candidate agents for type 2 diabetes treatment with computational bioinformatics approach.Foxp3 regulates megakaryopoiesis and platelet function.Platelet proteome changes associated with diabetes and during platelet storage for transfusion.Detection of clopidogrel hyporesponsiveness using a point-of-care assay and the impact of additional cilostazol administration after coronary stent implantation in diabetic patients.Vascular biology of metabolic syndromeMPV may reflect subcinical platelet activation in diabetic patients with and without diabetic retinopathy.Fibrinolytic activity in Nigerian diabetics.Risk factors for venous thromboembolism after total hip and total knee arthroplasty: a meta-analysis.Type 2 diabetes mellitus and myocardial ischemic preconditioning in symptomatic coronary artery disease patients.Loss of the insulin receptor in murine megakaryocytes/platelets causes thrombocytosis and alterations in IGF signalling.How to best manage glycemia and non-glycemia during the time of acute myocardial infarction.Matrix metalloproteinases and diabetic vascular complications.Increased Benefit With Vorapaxar Use in Patients With a History of Myocardial Infarction and Diabetes Mellitus: What the Data Show Us.Type II Diabetes Mellitus in Arabic-Speaking Countries.Unaltered Angiogenesis-Regulating Activities of Platelets in Mild Type 2 Diabetes Mellitus despite a Marked Platelet HyperreactivityRadionuclide-based insights into the pathophysiology of ischemic heart disease: beyond diagnosis.Cardiometabolic aspects of the polycystic ovary syndrome.
P2860
Q26752613-355B155C-0897-439C-9BA9-9BD58C7AA01EQ26775125-C3AE6CB6-E432-4F00-AA38-FD482B41322CQ26782844-B843BD0B-7A2C-46A7-9ACE-BF15E92AC0A1Q26799591-BAEBE5A0-ABB6-4CD7-A2C8-36D105562146Q26801308-B6545BBB-2D79-4AB1-8002-9A1838D8E528Q26824002-3A26AC07-8251-4411-9163-315171642397Q28087462-3A151891-4B98-4CF4-8A43-5BD145087CD0Q28194526-B0C38A92-0D0B-4852-A365-BC2A9ED540B4Q28196731-0DA51205-9498-4286-9EE6-CF54152FD94CQ28220363-D564B257-A459-4C71-94C7-2FBD4E795637Q28354107-62DD7133-3792-4270-9415-C0A30F91A31EQ28481709-777EF871-E3AE-4F2B-91C4-DE526F0E984CQ30250347-20391BCB-CC65-481B-B434-1EE54C754C16Q30420690-53F151A0-1A7E-4E28-958B-F15265EEAA19Q33646596-4661952B-A137-4FEF-916B-8DFEDF485FCEQ33756264-1F55D7D9-E9BD-44C9-9A0A-6E92D894CD31Q33855470-F3B6C619-8A0C-4168-B69F-4A58742B31E4Q33927945-6ACF91C0-6123-42C6-AFE2-A8279C3B1660Q34002877-75DD73FE-E2B4-4CB8-AA0E-664D31D67C18Q34050936-5D194796-738E-41C9-921F-ECF9F14AEDFCQ34146486-1C60953F-DD9F-46F2-B57C-B283EED2F44BQ34167250-72352928-3AA6-43C7-B9F6-A675752BE4ECQ34431756-92797D30-E800-4379-8B38-0A69918BC07BQ34460943-B2B268A5-47A9-4069-AE2A-0F11DE19025DQ34474690-FDAAF9A6-2D5C-4F10-B5F6-AACF99DEE13CQ34474697-3DC221BB-6FB4-4EA8-ADDA-4AC792F3E277Q35033557-82A0BB33-D9B1-49AD-B167-07C57303805FQ35106315-B082FE0E-CBF9-4A51-873F-610B0DC04C18Q35196856-C95361E6-8C4F-43A5-A341-B3B16B9B3F6AQ35520503-7F6B63C3-38FD-4B25-8616-880A4E6D3EC4Q35597753-CADF26F1-B6E5-492C-B153-1CB202A64CEEQ35672947-C0EBD6C5-919D-4B6F-9AF7-628E36E8A4C3Q35766245-2A5273F4-ADF3-4FD4-B5C0-3CE1F46A1A0FQ36072601-B6186F70-84AC-419B-9F2D-87E0867F2AD9Q36081593-7C665095-426A-4D7B-9AC5-3332D2224093Q36094523-8829C75E-8BF6-439B-B70C-4C9D5AA6B687Q36125083-953780B3-0401-4D76-BE24-2724A076B673Q36128546-49E0016D-4007-46A6-AD88-C485D3C4FC5DQ36172243-4999D18C-6FB3-4AF9-B429-720B5C83A7A6Q36287892-8B592C3D-9770-4BB5-BCB4-CF1F1AA87C72
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Platelet dysfunction in type 2 diabetes.
@ast
Platelet dysfunction in type 2 diabetes.
@en
Platelet dysfunction in type 2 diabetes.
@nl
type
label
Platelet dysfunction in type 2 diabetes.
@ast
Platelet dysfunction in type 2 diabetes.
@en
Platelet dysfunction in type 2 diabetes.
@nl
prefLabel
Platelet dysfunction in type 2 diabetes.
@ast
Platelet dysfunction in type 2 diabetes.
@en
Platelet dysfunction in type 2 diabetes.
@nl
P2093
P1433
P1476
Platelet dysfunction in type 2 diabetes.
@en
P2093
P304
P356
10.2337/DIACARE.24.8.1476
P407
P577
2001-08-01T00:00:00Z